Alzheimer's treatment

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.

When the brain is harmed by injury or disease, neurons die or degenerate. A Penn State researcher has developed an innovative technology for regenerating…